CJC-1295 vs Ipamorelin: What’s the Difference?

Please note: None of the compounds covered here have received FDA approval for human use. This piece is written for research and educational use only and is not intended as medical guidance or encouragement for individual use.

What Is CJC-1295?

CJC-1295 is a growth hormone–releasing hormone (GHRH) analog designed to stimulate sustained endogenous growth hormone secretion through pituitary activation.

What Is Ipamorelin?

Ipamorelin is a selective ghrelin mimetic that triggers short, pulsatile growth hormone release while minimizing stimulation of cortisol and prolactin.

Key Differences at a Glance

Feature	CJC-1295	Ipamorelin
Peptide Class	GHRH Analog	Ghrelin Mimetic
Half-Life	Long	Short
GH Release	Sustained	Pulsatile

Why Are CJC-1295 and Ipamorelin Often Combined?

When studied together, these peptides activate complementary growth hormone pathways, producing a broader and more physiologically relevant GH response.

Research Product Examples

Frequently Asked Questions

What is the main difference between CJC-1295 and Ipamorelin?
CJC-1295 provides long-lasting GH signaling, while Ipamorelin produces short GH pulses.

Can CJC-1295 and Ipamorelin be studied together?
Yes, they are frequently researched together due to complementary mechanisms.

FTC Disclosure: Some links on this page are affiliate links. This means Peptide News may earn a commission if you choose to take a qualifying action through those links, at no additional cost to you.

Disclaimer: This content is for informational purposes only. Products referenced are sold for research use only and are not intended for human consumption.

Visit Peptide-News.com